Eight Sleep needs the FDA to turn a $2,999 mattress cover into a billable device

The distinction Eight Sleep is chasing is narrow, and it carries the whole business case. Apple's Watch and Samsung's Galaxy Watch and Ring have been cleared since 2024 to flag apnea "risk", and the FDA's bar for detecting apnea sits below its bar for diagnosing it ^[5]. Eight Sleep says it is going after the prescription-based diagnostic aid instead, and expects to report apnea events per hour rather than tell a sleeper they show signs of something ^[6]. Events per hour is a number a clinician can act on. A risk flag is not.

The catch is who is already standing in that lane. The prescription diagnostic route contains existing home sleep-testing devices ^[16], so any reimbursement discussion gets priced against those rather than against a $2,999 cover endorsed by Elon Musk and Mark Zuckerberg ^[1]. The company says it is working on making the Pod more affordable, and Fortune's own reading is that it is not clear how that happens without a different cost structure ^[20].

Then the arithmetic behind the valuation. Tether's $50 million came in at $1.5 billion in March, at a company that was profitable last year ^[13]. At list price, that valuation equals roughly 500,000 mattress covers of gross hardware revenue ^[18], which is a large number of households willing to spend three thousand dollars on bedding before the software bill arrives.

That bill is the part payers will find strange. Automatic control and tracking require $199 to $399 a year, and without a subscription the Pod is a set of manual temperature buttons ^[11]. Five years at the top tier adds about $1,995, close to two thirds of the hardware price again ^[19]. A measurement function that switches off when a card expires is an awkward object to hand a benefits manager. HSA and FSA eligibility through Truemed already exists ^[12], and that changes the tax treatment of the purchase, not the payer.

The evidence base sets the timeline. One independent study on the Pod's benefits has been published, alongside preprints that point the right way but are not yet independently verified, plus apnea studies that Eight Sleep funded itself ^[9]. The de-identified user data pile supports trend research ^[10], which is not the same as supporting a submission. Franceschetti trained as a securities lawyer in Milan and is neither an engineer nor a doctor ^[14]; the next stretch of this company's life is a regulatory filing, so that may be the more useful background. Meanwhile the marketing budget is doing what it did before, including a reportedly eight-figure Aston Martin Aramco partnership signed in February 2026 ^[17], against a stated ambition to build the biggest health technology company in the world ^[15].